The Bulgarian Drug Agency issued a new Marketing Authorisation for Bortezomib-Tchaikapharma

Bortezomib-Tchaikapharma 3.5 mg powder for solution for injection is Tchaikapharma High Quality Medicines’ newest medicinal product which obtained a Marketing Authorisation by the Bulgarian Drug Agency in the beginning of February 2017. The active substance contained is Bortezomib (as a mannitol boronic ester).

The medicinal product is subject to medical prescription.

ATC code: L01XX 32